Immuvera launches capital raise

Immuvera strengthens board with two strategic appointments

Immuvera Therapeutics on the Radforsk Podcast

From Alv B to Immuvera Therapeutics: a name that reflects our mission

Patent grant strengthens Immuvera’s intellectual property portfolio

Immuvera strengthens its leadership team with seasoned Chief Technology Officer and Head of Regulatory Affairs